Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1996

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Reintroducing DMPA to the Philippine family planning program: a longitudinal

study of continuing users and drop-outs, Philippines. Final report. Family

Planning Operations Research and Training (FPORT) Program.

AUTHORS

Population Council. Asia and Near East Operations Research and Technical

Assistance Project; Philippines. Department of Health

SOURCE

Manila, Philippines, Population Council, Asia and Near East Operations Research

and Technical Assistance Project, 1996 Apr. x, 57 p. USAID Contract No. DPE-

3030-Q-00-0023-00

ABSTRACT

In 1994 in the Philippines, the Department of Health reintroduced the contraceptive injectable DMPA in 10 local

government units as part of its first phase. To provide the DMPA Reintroduction Program insight into the

perspectives of DMPA acceptors, interviews were conducted twice with 812 acceptors of the contraceptive injectable

Depo-Provera (DMPA) from Baguio City, Quezon City, Laguna, and Pangasinan in Luzon; Iloilo City and Cebu in the

Visayas; and Davao City, Davao del Sur, South Cotabato and Surigao del Sur in Mindanao in February 1995 and

again in June-July 1995. The study focused on factors falling under the classification of socioeconomic and

demographic characteristics, reproductive history, contraceptive history, adoption of DMPA, quality of care related to

DMPA, experience with DMPA, husband-wife communication on family size and family planning, and attitudes

towards DMPA held by relatives and peers. Limited or no previous family planning use before accepting DMPA (odds

ratio [OR] = 1.57-1.67), the presence of a supportive husband (OR = 2.46), husband's desire for more children (OR =

1.57), warm interpersonal relations between providers and clients (OR = 10.7), provision of appropriate information

about side effects (OR = 3.25), and resort to proper pre-screening questions prior to dispensing DMPA (OR = 1.55)

contributed significantly to the decision to continue using DMPA. These findings suggest that the DMPA

Reintroduction Program should pay more attention to male outreach activities and to quality of care in providing

family planning services in order to increase acceptance and continued use of DMPA. (PubHealth.info Document ID:

CONT2T 2055-06)

PubHealth.info NOTE: The author(s) of this article titled, "Reintroducing DMPA to the Philippine family planning

program: a longitudinal study of continuing users and drop-outs, Philippines. Final report. Family Planning

Operations Research and Training (FPORT) Program.", is(are) Population Council. Asia and Near East Operations

Research and Technical Assistance Project; Philippines. Department of Health. The source of this article is

"Manila, Philippines, Population Council, Asia and Near East Operations Research and Technical Assistance

Project, 1996 Apr. x, 57 p. USAID Contract No. DPE-3030-Q-00-0023-00". This article was published in 1996 in

English language(s). (PubHealth.info® Document ID: CONT2T 2055-06. All rights reserved with PubHealth.info) PIN:

7055

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.